BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32441647)

  • 1. Rituximab in severe immunoglobulin-A vasculitis (Henoch-Schönlein) with aggressive nephritis.
    Fenoglio R; Sciascia S; Naretto C; De Simone E; Del Vecchio G; Ferro M; Quattrocchio G; Roccatello D
    Clin Exp Rheumatol; 2020; 38 Suppl 124(2):195-200. PubMed ID: 32441647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein).
    Maritati F; Fenoglio R; Pillebout E; Emmi G; Urban ML; Rocco R; Nicastro M; Incerti M; Goldoni M; Trivioli G; Silvestri E; Mohammad AJ; Jayne D; Eriksson P; Segelmark M; Novikov P; Harris H; Roccatello D; Vaglio A
    Arthritis Rheumatol; 2018 Jan; 70(1):109-114. PubMed ID: 28973844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab treatment for IgA vasculitis: A systematic review.
    Hernández-Rodríguez J; Carbonell C; Mirón-Canelo JA; Diez-Ruiz S; Marcos M; Chamorro AJ
    Autoimmun Rev; 2020 Apr; 19(4):102490. PubMed ID: 32062030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature.
    Crayne CB; Eloseily E; Mannion ML; Azerf SP; Weiser P; Beukelman T; Stoll ML; Feig DI; Prescott Atkinson T; Cron RQ
    Pediatr Rheumatol Online J; 2018 Nov; 16(1):71. PubMed ID: 30428889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult-onset IgA vasculitis (Henoch-Schönlein): Update on therapy.
    Maritati F; Canzian A; Fenaroli P; Vaglio A
    Presse Med; 2020 Oct; 49(3):104035. PubMed ID: 32645417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case of Gut Necrosis in Adult-Onset Immunoglobulin A Vasculitis (Henoch-Schönlein Purpura).
    Weissman AS; Patel VS; Mushfiq O
    J Investig Med High Impact Case Rep; 2020; 8():2324709620925565. PubMed ID: 32434396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of kidney biopsy findings with short- and medium-term outcomes in children with moderate-to-severe IgA vasculitis nephritis.
    Clavé S; Sordet M; Tsimaratos M; Decramer S; Fila M; Guigonis V; Faudeux C; Daniel L; Torrents J; Boucekine M; Harambat J; Rousset-Rouvière C
    Eur J Pediatr; 2021 Oct; 180(10):3209-3218. PubMed ID: 33934234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H; Lee SM; Manno RL; Seo P; Geetha D
    Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort.
    Berthelot L; Jamin A; Viglietti D; Chemouny JM; Ayari H; Pierre M; Housset P; Sauvaget V; Hurtado-Nedelec M; Vrtovsnik F; Daugas E; ; Monteiro RC; Pillebout E;
    Nephrol Dial Transplant; 2018 Sep; 33(9):1579-1590. PubMed ID: 29126311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature.
    Fenoglio R; Naretto C; Basolo B; Quattrocchio G; Ferro M; Mesiano P; Beltrame G; Roccatello D
    Immunol Res; 2017 Feb; 65(1):186-192. PubMed ID: 27449502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of outcome in Henoch-Schönlein nephritis in children and adults.
    Coppo R; Andrulli S; Amore A; Gianoglio B; Conti G; Peruzzi L; Locatelli F; Cagnoli L
    Am J Kidney Dis; 2006 Jun; 47(6):993-1003. PubMed ID: 16731294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgA Vasculitis: Genetics and Clinical and Therapeutic Management.
    González-Gay MA; López-Mejías R; Pina T; Blanco R; Castañeda S
    Curr Rheumatol Rep; 2018 Apr; 20(5):24. PubMed ID: 29611051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular, thromboembolic and renal outcomes in IgA vasculitis (Henoch-Schönlein purpura): a retrospective cohort study using routinely collected primary care data.
    Tracy A; Subramanian A; Adderley NJ; Cockwell P; Ferro C; Ball S; Harper L; Nirantharakumar K
    Ann Rheum Dis; 2019 Feb; 78(2):261-269. PubMed ID: 30487151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab as add-on therapy in patients with resistant lupus nephritis who have failed induction or maintenance therapy with other agents: A real-world experience from a single center in Mumbai.
    Yadav S; Balakrishnan C; Mangat G; Kothari J
    Lupus; 2024 Jan; 33(1):88-95. PubMed ID: 38048588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive biomarkers of IgA vasculitis with nephritis by metabolomic analysis.
    Demir S; Kaplan O; Celebier M; Sag E; Bilginer Y; Lay I; Ozen S
    Semin Arthritis Rheum; 2020 Dec; 50(6):1238-1244. PubMed ID: 33065418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct characteristics and outcomes in elderly-onset IgA vasculitis (Henoch-Schönlein purpura) with nephritis: Nationwide cohort study of data from the Japan Renal Biopsy Registry (J-RBR).
    Komatsu H; Fujimoto S; Maruyama S; Mukoyama M; Sugiyama H; Tsuruya K; Sato H; Soma J; Yano J; Itano S; Nishino T; Sato T; Narita I; Yokoyama H
    PLoS One; 2018; 13(5):e0196955. PubMed ID: 29738576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing immunoglobulin A vasculitis (Henoch-Schönlein purpura) in children and adults: a single-centre study from Turkey.
    Batu ED; Sarı A; Erden A; Sönmez HE; Armağan B; Kalyoncu U; Karadağ Ö; Bilginer Y; Akdoğan A; Kiraz S; Özen S
    Scand J Rheumatol; 2018 Nov; 47(6):481-486. PubMed ID: 29912602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of histological crescent formation in patients with IgA vasculitis (Henoch-Schönlein purpura)-related nephritis: a cohort in the adult Chinese population.
    Huang X; Wu J; Wu XM; Hao YX; Zeng CH; Liu ZH; Tang Z
    BMC Nephrol; 2018 Nov; 19(1):334. PubMed ID: 30466400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis.
    Alberici F; Smith RM; Jones RB; Roberts DM; Willcocks LC; Chaudhry A; Smith KG; Jayne DR
    Rheumatology (Oxford); 2015 Jul; 54(7):1153-60. PubMed ID: 25477054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents.
    Delbet JD; Hogan J; Aoun B; Stoica I; Salomon R; Decramer S; Brocheriou I; Deschênes G; Ulinski T
    Pediatr Nephrol; 2017 Jul; 32(7):1193-1199. PubMed ID: 28204946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.